Chemokine receptor-ligand interactions measured using time-resolved fluorescence
1Pharmacopeia Inc., 101 College Road East, Princeton, New Jersey 08540, USA. inglese@pharmacop.com
Biochemistry
|March 28, 1998
Summary
Researchers developed a novel europium-labeled Interleukin-8 (IL8) ligand to measure binding activity with CXCR1 and CXCR2 receptors. This stable, sensitive method offers a nonradioactive alternative for studying receptor-ligand interactions.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- G protein-coupled receptor subtypes CXCR1 and CXCR2 mediate Interleukin-8 (IL8) signaling.
- Accurate measurement of chemokine receptor-ligand interactions is crucial for understanding cellular responses.
Purpose of the Study:
- To develop a nonradioactive, lanthanide-chelate derivatized IL8 ligand for measuring binding activity to CXCR1 and CXCR2.
- To assess the utility of lanthanide-labeled proteins in studying receptor-ligand interactions.
Main Methods:
- Site-specific mutagenesis of IL8 to create IL8-S72C with a single free sulfhydryl group.
- Conjugation of an iodoacetamide derivative of the Eu3+-chelate of DTTA to IL8-S72C, yielding [Eu3+]IL8-S72C.
- Measurement of dissociation constants using time-resolved fluorometry on CHO cells expressing CXCR1 or CXCR2.
Main Results:
- Successfully synthesized a europium-labeled IL8 conjugate ([Eu3+]IL8-S72C) with one Eu3+ per IL8 molecule.
- The dissociation constant of [Eu3+]IL8-S72C was comparable to radiolabeled IL8 (approximately 2 nM).
- Demonstrated high sensitivity, stability, and specific activity of the europium-labeled IL8.
Conclusions:
- Lanthanide-labeled proteins, exemplified by europium-labeled IL8, are effective tools for measuring receptor-ligand interactions.
- This nonradioactive approach offers a viable alternative to radioligands for studying chemokine receptor binding.
- The methodology can potentially be extended to other peptide ligands and receptor systems.


